PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-06 (5)

Date Title Company
06-Feb-2024 Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis Businesswire